More Video... New Guidelines for Treating Heat Stroke Heat Stroke Can Be Deadly if Not Treated Rapidly MGN Online Its finally here -- summer time! But the heat in the summer months can be deadly for athletes, or anyone working outdoors. Mark Beversdorf has been running since he can remember. Now, as an active triathlete, he knows the dangers of working out in the the hot, summer sun, and the potential for heat stroke. "What I notice is I stop sweating, and that's not a good sign," Mark said, "especially when its hot. That means you're really running out of liquid in your body if you stop sweating." The National Athletic Trainer's Association recently released new guidelines to change how athletes and coaches deal with heat stroke. They say everyone involved in athletics needs to know what quick actions to take if someone is showing symptoms. "When you reach the heat stroke part, your skin becomes very warm and very dry, so your body isn't able to compensate anymore so you stop the sweating process," Josh Finke, the EMS Division Chief at the Wausau Fire Department said, "your body isn't able to keep up with the amount of heat your … Continue reading →

July 1, 2014 - Designed to optimize minimally invasive image-guided neurological interventions, NeuroSuite consists of bi-plane interventional X-ray system with combination of 2 detectors. Frontal FD20 detector delivers live 2D/3D imaging for live navigation and immediate therapy feedback, while smaller, lateral FD15 detector is positioned beyond shoulders and very close to head. Combination provides sharp, full brain imaging at lower X-ray dose and 3D imaging optimized for neuro and spine interventions. Philips Semiconductors Div., Royal Philips Electronics 811 E. Arques Ave. Sunnyvale, CA, 94088 USA Press release date: June 23, 2014 NeuroSuite interventional X-ray system enhances minimally invasive neurological treatment Solution supports more effective device guidance and placement in live image-guided neuroradiology procedures, extending treatment options First installation at Karolinska University Hospital Sweden Royal Philips (NYSE: PHG, AEX: PHIA) today announced the introduction of NeuroSuite, a new integrated solution designed to support and enhance minimally invasive image-guided neurological interventions, a fast growing market with a compound annual growth rate of around 9 percent. Philips' new interventional X-ray solution offers more effective device guidance and placement in every neuroradiology procedure. The first NeuroSuite system was recently installed at Karolinska University Hospital, Stockholm, Sweden. This hospital is one of the worlds leading … Continue reading →

Irvine, CA and Annapolis Junction, MD (PRWEB) June 30, 2014 Proove Biosciences, the commercial and research leader in personalized medicine, presented research and exhibited the companys genetic testing products and services at the 2014 Florida Academy of Pain Medicine(FAPM) Scientific Meeting. The meeting was held in conjunction with the Florida Society of Physical Medicine and Rehabilitation and the American Academy of Regenerative Orthopedic Medicine. The research studies that we showcase illustrate how genetic testing can be an integral part of an effective personalized pain treatment regimen, stated Brian Meshkin, President of Proove Biosciences. Failed treatments for uncontrolled chronic pain lead to escalating healthcare costs and unnecessary patient suffering. FAPMs meeting is the premier event for pain treatment professionals, researchers, and practitioners. The conference is designed to promote a better understanding of pain and features the latest products and techniques for pain management and diagnosis. In addition to scientific sessions, this years meeting included three hands-on preconference workshops and panel discussions about the legal and political challenges facing the practice of medicine. Florida has a startlingly high rate of prescription drug abuse and overdose deaths, and both the State and FAPM are on the cutting edge of developing new methods to … Continue reading →

PUBLIC RELEASE DATE: 30-Jun-2014 Contact: Kathryn Ruehle kruehle@liebertpub.com 914-740-2100 Mary Ann Liebert, Inc./Genetic Engineering News New Rochelle, NY, June 30, 2014St. John's wort is the most frequently used complementary and alternative medicine (CAM) treatment in the U.S. for depression and similar psychiatric disorders. The many commonly prescribed medications that St. John's wort can interact withsometimes with serious consequences such as serotonin syndrome or heart diseaseare reviewed in The Journal of Alternative and Complementary Medicine, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The article is available free on The Journal of Alternative and Complementary Medicine website. In the article "Use of St. John's Wort in Potentially Dangerous Combinations", Scott Davis, Steven Feldman, MD, PhD, and Sarah Taylor, MD, Wake Forest Baptist Medical Center, Winston-Salem, NC, present the results of a large-scale search of a national medical database across 17 years to assess how often St. John's wort is prescribed and taken with other medications that may result in adverse reactions, such as oral contraceptives, selective serotonin reuptake inhibitors (SSRIs), blood thinners, chemotherapy medicines, digoxin, statins, immunosuppressants, or HIV medicines, for example. About the Journal The Journal of Alternative and Complementary Medicine is a monthly peer-reviewed journal publishing observational, clinical, … Continue reading →